← All organizations
Vifor Inc.
Also known as: Galenica | Galenica SA | VIFORFRANCE | Vifor Inc. | Vifor (International) Inc. | Vifor Pharma | VIFOR PHARMA | Vifor Pharma, CH-8152 Glattbrugg, Switzerland | Vifor Pharma Group | Vifor Pharma, Inc. | Vifor Pharma Management Ltd.
Highest phase reached
Phase 4
Acquired by CSL Behring on Dec 14, 2021
Timeline
1920s
- Jun 1, 1927
Vifor Inc.— Founded
2000s
- Oct 17, 2007
Aspreva Pharmaceuticals— Acquired
- Nov 14, 2007
methoxy polyethylene glycol-epoetin beta— NDA Secondary Org
2010s
- Oct 21, 2015
patiromer— Marketing Organization
2020s
- Nov 22, 2021
Sanifit— Acquired
- Dec 1, 2021
Inositec— Acquired
- Dec 14, 2021
CSL Behring— Acquired By
Drugs by trial phase (40 distinct, 66 trials)
Phase 4 (11 own, 0 via acquisition)
Phase 3 (17 own, 5 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Phase 1 (5 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
- Anemia
- Anemia, Iron-Deficiency
- Aneurysm
- Aortic Aneurysm
- Aortic Aneurysm, Thoracic
- Aortic Valve Stenosis
- Attention Deficit Disorder with Hyperactivity
- beta-Thalassemia
- Breast Neoplasms
- Carcinoma, Ductal, Breast
- Colitis
- Colitis, Ulcerative
- Colorectal Neoplasms
- Coronary Artery Disease
- Crohn Disease
- Deficiency Diseases
- Dermatitis
- Dermatitis, Atopic
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Disease
- Eczema
- Familial Primary Pulmonary Hypertension
- Fatigue
- Gastrointestinal Hemorrhage
- Heart Failure
- Hemorrhage
- Hyperkalemia
- Hyperphosphatemia
- Hypertension
- Inflammatory Bowel Diseases
- Inflammatory Breast Neoplasms
- Intestinal Diseases
- Intracranial Aneurysm
- Kidney Diseases
- Multiple Myeloma
- Neoplasm Metastasis
- Osteoarthritis, Knee
- Postoperative Complications
- Pregnancy Complications
- Psychomotor Agitation
- Renal Insufficiency, Chronic
- Restless Legs Syndrome
- Syndrome
- Thalassemia
- Thrombocytosis
- Ulcer
- Vasculitis
- Vomiting
Marketed drugs (2)
Subsidiaries (3 direct, 3 total across the full acquisition tree)
Recent trials (50)
- NCT06434025CollaboratorPhase 3May 24, 2024
- NCT05766839Lead sponsorPhase 2Jan 31, 2024
- NCT05766839OfficialPhase 2Jan 31, 2024
- NCT05786469CollaboratorPhase 3Aug 2, 2023
- NCT05885763Study directorPhase 1Jun 26, 2023
- NCT05885737Study directorPhase 3May 30, 2023
- NCT05136664Study directorPhase 3Dec 31, 2021
- NCT05077436Lead sponsorPhase 1Oct 14, 2021
- NCT04938635Study directorPhase 2Sep 20, 2021
- NCT04938635Lead sponsorPhase 2Sep 20, 2021
- NCT04817670Study directorPhase 2Jun 9, 2021
- NCT04817670Lead sponsorPhase 2Jun 9, 2021
- NCT04616092CollaboratorPhase 4Nov 30, 2020
- NCT04364269Lead sponsorPhase 2Jun 30, 2020
- NCT04364269Study directorPhase 2Jun 30, 2020
Details
- Founded
- Berne, CH Jun 1, 1927
- Last known activity
- May 24, 2024
Notes
Formerly Galenica